| The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria XZ Li, P Plésiat, H Nikaido Clinical microbiology reviews 28 (2), 337-418, 2015 | 1440 | 2015 |
| Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium N Mesaros, P Nordmann, P Plésiat, M Roussel-Delvallez, J Van Eldere, ... Clinical microbiology and infection 13 (6), 560-578, 2007 | 836 | 2007 |
| Involvement of an Active Efflux System in the Natural Resistance of Pseudomonas aeruginosa to Aminoglycosides JR Aires, T Köhler, H Nikaido, P Plésiat Antimicrobial agents and chemotherapy 43 (11), 2624-2628, 1999 | 533 | 1999 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 483 | 2017 |
| In Vivo Emergence of Multidrug-Resistant Mutants ofPseudomonas aeruginosa Overexpressing the Active Efflux System MexA-MexB-OprM I Ziha-Zarifi, C Llanes, T Köhler, JC Pechere, P Plesiat Antimicrobial Agents and Chemotherapy 43 (2), 287-291, 1999 | 392 | 1999 |
| Resistance to polymyxins in Gram-negative organisms K Jeannot, A Bolard, P Plesiat International journal of antimicrobial agents 49 (5), 526-535, 2017 | 371 | 2017 |
| Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps Simultaneously C Llanes, D Hocquet, C Vogne, D Benali-Baitich, C Neuwirth, P Plésiat Antimicrobial agents and chemotherapy 48 (5), 1797-1802, 2004 | 364 | 2004 |
| The Pseudomonas aeruginosa opportunistic pathogen and human infections S De Bentzmann, P Plésiat Environmental microbiology 13 (7), 1655-1665, 2011 | 361 | 2011 |
| Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients L Armand-Lefèvre, C Angebault, F Barbier, E Hamelet, G Defrance, ... Antimicrobial agents and chemotherapy 57 (3), 1488-1495, 2013 | 318 | 2013 |
| Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy F Van Bambeke, Y Glupczynski, P Plesiat, JC Pechere, PM Tulkens Journal of Antimicrobial Chemotherapy 51 (5), 1055-1065, 2003 | 276 | 2003 |
| Mutations in β-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins M Berrazeg, K Jeannot, VY Ntsogo Enguéné, I Broutin, S Loeffert, ... Antimicrobial agents and chemotherapy 59 (10), 6248-6255, 2015 | 269 | 2015 |
| A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams in Pseudomonas aeruginosa C Muller, P Plésiat, K Jeannot Antimicrobial agents and chemotherapy 55 (3), 1211-1221, 2011 | 269 | 2011 |
| Outer membranes of Gram‐negative bacteria are permeable to steroid probes P Plesiat, H Nikaido Molecular microbiology 6 (10), 1323-1333, 1992 | 252 | 1992 |
| Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa T Köhler, M Michea-Hamzehpour, P Plesiat, AL Kahr, JC Pechere Antimicrobial agents and chemotherapy 41 (11), 2540-2543, 1997 | 247 | 1997 |
| MexXY-OprM Efflux Pump Is Necessary for Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides D Hocquet, C Vogne, F El Garch, A Vejux, N Gotoh, A Lee, O Lomovskaya, ... Antimicrobial agents and chemotherapy 47 (4), 1371-1375, 2003 | 240 | 2003 |
| The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? A Bannay, B Hoen, X Duval, JF Obadia, C Selton-Suty, V Le Moing, ... European heart journal 32 (16), 2003-2015, 2011 | 234 | 2011 |
| Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa D Hocquet, P Nordmann, F El Garch, L Cabanne, P Plésiat Antimicrobial agents and chemotherapy 50 (4), 1347-1351, 2006 | 195 | 2006 |
| Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa T Köhler, M Kok, M Michéa-Hamzehpour, P Plesiat, N Gotoh, T Nishino, ... Antimicrobial agents and chemotherapy 40 (10), 2288-2290, 1996 | 187 | 1996 |
| Induction of the MexXY Efflux Pump in Pseudomonas aeruginosa Is Dependent on Drug-Ribosome Interaction K Jeannot, ML Sobel, F El Garch, K Poole, P Plésiat Journal of Bacteriology 187 (15), 5341-5346, 2005 | 181 | 2005 |
| Dechlorination of atrazine by a Rhizobium sp. isolate C Bouquard, J Ouazzani, J Prome, Y Michel-Briand, P Plesiat Applied and Environmental Microbiology 63 (3), 862-866, 1997 | 181 | 1997 |
